Related Experiment Video
Updated: Feb 5, 2026
03:47
Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
1.2K
Frailty in Heart Failure: Implications for Management.
Cristiana Vitale1, Ilaria Spoletini1, Giuseppe Mc Rosano1
1Centre for Clinical and Basic Research, Department of Medical Sciences, IRCCS San Raffaele Pisana Rome, Italy.
Cardiac Failure Review
|September 13, 2018
Summary
Frailty, a syndrome of aging and illness, significantly impacts cardiovascular disease, particularly heart failure (HF). This review explores frailty in HF and its management strategies.
Area of Science:
- Gerontology
- Cardiology
- Clinical Medicine
Background:
- Frailty is a complex clinical syndrome linked to aging and chronic illness, characterized by decreased physiological reserves and increased vulnerability.
- The prevalence and impact of frailty in cardiovascular disease, especially heart failure (HF), are increasingly recognized.
- A significant proportion of heart failure patients (up to 79%) exhibit frailty, correlating with diminished quality of life and poorer prognosis.
Purpose of the Study:
- To review the existing literature on the prevalence and implications of frailty in heart failure.
- To highlight current understanding of frailty as a predictor of outcomes in cardiovascular disease.
- To identify and summarize potential management strategies for frailty in heart failure patients.
Main Methods:
- Systematic literature review of studies investigating frailty in heart failure.
- Analysis of data on frailty prevalence, associated outcomes, and management approaches.
- Synthesis of findings to provide a comprehensive overview of the topic.
Main Results:
- Frailty is highly prevalent in heart failure populations, affecting up to 79% of patients.
- Frailty is consistently associated with adverse outcomes, including reduced quality of life and increased mortality.
- Evidence suggests that interventions targeting frailty may improve patient outcomes.
Conclusions:
- Frailty is a critical factor in heart failure management, impacting prognosis and quality of life.
- Early identification and management of frailty are essential for optimizing care in heart failure patients.
- Further research is needed to establish definitive management guidelines for frailty in cardiovascular disease.
Related Concept Videos
01:30Heart Failure V: Medical Management
330
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
330
01:29Heart Failure II: Pathophysiology
952
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
952
01:17Pathophysiology of Heart Failure
3.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.8K
01:27Heart Failure I: Introduction
903
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
903
01:22Heart Failure VI: Adjunct Therapies
348
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
348
01:22Heart Failure Drugs: Diuretics
983
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
983